Synopses & Reviews
New surgical and non-surgical measures that carriers of the breast cancer gene can take for prevention; Use of tamoxifen cream and freezing of fibroadenomas; Blood tests for breast cancer - now in development. New data on which breast cancer patients need chemotherapy (only about 25 per cent of postmenopausal patients) and which need only tamoxifen; MRI and ultrasound tests: how well they work in comparison with mammograms; The new aromatase inhibitors that may replace tamoxifen and have fewer side effects; More localized radiation and highly targeted therapies; Metastatic disease: new therapies and new survival curves; New data on lobular carcinoma in situ (LCIS) that will change the way it is viewed and treated; New statistics on sentinel node biopsy (removing just key lymph nodes instead of 10-12, which can cause lifelong side effects, such as infections and swelling) and its accuracy.
Recent research is rapidly changing the diagnosis, treatment, and outcomes of breast cancer. Just as women afflicted with or worried about breast cancer have turned to the earlier editions of Dr. Susan Love's guide for the soundest, most supportive advice, once again they will find all the help they need in this new edition. From guidance on screening techniques and benign disease to comprehensive and heartening advice on living with breast cancer, Dr. Love's book will be a priceless help to recovery on every level, medical, practical, and psychological. Once again readers will lean with gratitude on the extraordinary empathy and expertise in the book that Newsweek called "One of the most complete and trustworthy books ever published on breast cancer."
Now in a completely updated new edition-the most trusted, most authoritative guide to breast cancer diagnosis and treatment
About the Author
Susan M. Love, M.D., MBA, lives in Pacific Palisades, California. She is a member of the faculty of UCLA School of Medicine and Director of the Santa Barbara Breast Cancer Institute. A trusted authority on women's health, she was appointed by President Clinton to the National Cancer Advisory Board and is a Board Member of the National Breast Cancer Coalition.